Vaccinex Inc: Surges on multi-project deals
19/02/2021 13:39
** Biotech co's shares VCNX.O rise as much as 88.8% to
$5.5 premarket, set for best day ever
** Signs multi-project deals with two undisclosed prominent
pharmaceutical companies urn:newsml:reuters.com:*:nGNX95r1RS
** Collaboration to focus on ActivMAb, VCNX's antibody
discovery and novel viral display platform
** Financial terms of the deals undisclosed
** Up to Thursday's close, stock up ~38% YTD
(Reporting by Shivani Kumaresan in Bengaluru)
((Shivani.Kumaresan@thomsonreuters.com; +1 646 223 8780;))
Recent news on Vaccinex
See all newsBrief: Vaccinex Reports Third Quarter 2024 Financial Results And Provides Corporate Update
Brief: Vaccinex Says On Oct 7, Got Letter From The Nasdaq Listing Staff Stating That Co Had Not Regained Compliance With The Equity Standard
Brief: VaccinexExercise Of Warrants For $6.2 Million In Gross Proceeds
Brief: Vaccinex Provides Update On New Findings For Signal-Ad Phase 1B/2 Trial Of Pepinemab In Alzheimer’S Disease
Brief: Vaccinex Reports Completion of Last Patient Visit in Randomized, SIGNAL-AD Phase 1b/2 Study of Pepinemab Treatment for Alzheimer’s Disease